Avenacy Announces Launch of Palonosetron Hydrochloride Injection, USP in the U.S. Market
Represents the Company's twelfth product launch since inception in October 2023SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable
Jefferies Adjusts Eisai's Price Target to 7,000 Yen From 6,300 Yen, Keeps at Hold
Eisai (TYO:4523) has an average rating of outperform and price targets ranging from 5,000 yen to 11,400 yen, according to analysts polled by Capital IQ.Price (JPY): $6575.00, Change: $-29.00,
Nikkei Average Contribution Ranking (Morning) ~ Nikkei Average has fallen for 3 consecutive days, and First Retail has pushed down about 34 yen per share in one stock.
As of the closing of the market on the 19th, the number of rising stocks among the Nikkei Stock Average constituent stocks was 34, the number of falling stocks was 190, and the number of unchanged stocks was 1. The Nikkei Average has fallen for three consecutive days. At the end of the morning session, it was JPY 39,952.62 (with volume roughly estimated at 705.0 million shares), down by JPY 173.73 (-0.43%) from the previous day. The U.S. stock market fell on the 18th. Dow Inc fell 533.06 points (-1.29%) to 40,665.02 dollars, and Nasdaq fell 125.70 points (-0.70%) to 17,871.
Nikkei Average Contribution Ranking (Morning Close) ~ The Nikkei Average fell significantly, and Tohoku Electric pushed down about 310 yen in one stock.
As of the closing on the 18th, the number of rising stocks among the Nikkei average constituent stocks was 93, with 130 falling and 2 unchanged. The Nikkei average fell significantly. It closed the morning session at 40,277.86 yen (approx. 807 million 0.8 billion 70 million shares traded), down 819.83 yen (-1.99%) from the previous day. On the 17th, the US stock market was mixed. The Dow Jones Industrial Average rose 243.60 points (+0.59%) to 41,198.08, while the Nasdaq fell 512.41 points (-2.77%) to 179.
Cosmos Pharmaceuticals, 7&I-HD, etc. (additional) Rating
Target stock price change code | Stock name | Securities company | Previous | After change | ------ | ------------- | ------------- | --------- | --------- | <2802> | Ajinomoto | GS | 6800 yen | 7000 yen | <2914> | JT | GS | 4400 yen | 4600 yen | <3349> | Cosmos Pharmaceutical | Mizuho
Nikkei average contribution ranking (prelude) - Nikkei average slightly rising, Shinetsu Chemical pushing up about 13 yen with one stock.
As of the close on the 17th, the number of rising stocks among the Nikkei average constituent stocks was 172, the number of falling stocks was 49, and the number of unchanged stocks was 4. The Nikkei average continued to rise slightly. It closed the morning session at 41,307.36 yen (+0.08%), up 32.28 yen from the previous day. The volume was approximately 820 million shares traded. On the 16th, the US stock market continued to rise. The Dow Jones Industrial Average rose 742.76 points (+1.85%) to 40,954.48 dollars, while Nasdaq rose 36.77 points (+0.20%) to 18,509.3.
The rise is not enough even as a rebound of self-discipline.
The Nikkei average rebounded, closing at 41,275.08 yen, up 84.40 yen (+0.20%) with volume of about 1.6 billion 10 million shares traded. Buyers aimed for autonomous rebound from the recoil that had dropped more than 1000 yen last week, and the Tokyo market, which resumed trading after the 3-day holiday, started with buying. The Nikkei average expanded its gains to 41,520.07 yen in the mid-morning session. However, it could not break free from the range of self-rebound against the sharp decline, hovering around the psychological milestone of 41,500 yen.
The afternoon Nikkei average started 169 yen higher, with Kawasaki Heavy Industries and Ryohin Keikaku, etc. being high.
[Nikkei average stock price/TOPIX (Table)] Nikkei average; 41359.90; + 169.22 TOPIX; 2914.67; + 20.11 The afternoon Nikkei average narrowed its gains slightly from the morning close (41399.72 yen) at the start of trading, rising 169.22 yen from the previous day. During lunchtime, Nikkei 225 futures were in a range of 41340 yen to 41430 yen. The dollar/yen rate was around 158.60-70 yen since around 9 a.m.
Nikkei average contribution ranking (pre-opening) ~ Nikkei average rebound, TDK pushed up about 43 yen per share by one stock.
As of the closing of the 16th, the number of rising stocks among the Nikkei average constituent stocks was 138, falling stocks were 84, and unchanged stocks were 3. The Nikkei average rebounded. It closed the morning session at 41,399.72 yen (+0.51%) which was 209.04 yen higher than the previous trading day (approximate volume of 810 million 10 thousand shares traded). On the 15th, the US stock market continued to rise. The Dow Jones Industrial Average rose by 210.82 dollars (+0.53%) to 40,211.72 dollars, and the NASDAQ rose by 74.12 points (+0.40%) to 18,472.
Three points to watch in the afternoon session - Trump rally strengthens, including defense-related developments.
In the afternoon of the 16th, we want to focus on the following three points in trading: ・Nikkei Average rebounded, Trump rally strengthened in defense-related sectors ・Dollar-yen is solid, due to relief in U.S. interest rates ・Top contributors to price increases were TDK <6762> and Toshiba Elex <8035>. ■Nikkei Average rebounds, Trump rally strengthens in defense-related sectors Nikkei Average rebounds. It closed at 41,399.72 yen (volume approx. 810 million shares) during morning trading, up 209.04 yen (+0.51%) from the previous business day.
The Nikkei average rebounded, with a development that Trump Rally strengthened, including defense-related industries.
The Nikkei average rebounded. It closed the morning trading at 41,399.72 yen (+0.51%) higher than the previous day’s trading volume of approximately 810 million shares. On the 15th, the US stock market continued to rise. The Dow Jones Industrial Average rose by 210.82 points (+0.53%) to 40,211.72, the NASDAQ rose by 74.12 points (+0.40%) to 18,472.57, and the S&P 500 rose by 15.87 points (+0.28%) to 5,631.22 at the end of trading. After the assassination attempt incident, the
Signed a licensing agreement for Hostarabconazole with Sato Pharmaceutical in Asia and Oceania.
Eisai Co., Ltd. (Headquarters: Tokyo, Representative Executive Officer and CEO: Haruo Naito) hereby announces that it has entered into a license agreement with Sato Pharmaceutical Co., Ltd. (Headquarters: Tokyo, hereinafter referred to as Sato Pharmaceutical) for the development and commercialization of the antifungal agent Hosurabuconazole for fungal diseases in Asia and Oceania.
Analysts Offer Insights on Healthcare Companies: Eisai Co (OtherESALF) and Amgen (AMGN)
Biogen, Eisai Get Approval for Leqembi in Israel for Treatment of Alzheimer's Disease
Biogen (BIIB) and Eisai said Friday that the Leqembi has been approved in Israel for the treatment of patients with Alzheimer's disease.The drug should be initiated in patients with mild cognitive
Nikkei Average Contribution Ranking (Closing Bell) - Nikkei Average fell significantly for the first time in 4 days, with two stocks, Toshiba and Fast Retailing, lowering approximately 445 yen.
At the close on the 12th, the number of rising stocks of Nikkei average constituent stocks was 65, the number of falling stocks was 159, and the number of unchanged stocks was 1. On the 11th, the US stock market was mixed. The Dow Jones average closed at 39,753.75, up 32.39 points (+0.08%), the Nasdaq closed at 18,283.41, down 364.04 points (-1.95%), and the S&P 500 closed at 5,584.54, down 49.37 points (-0.88%). The June Consumer Price Index (CPI) showed sluggish inflation.
BioArctic Partnership Secures Israeli Approval for Alzheimer's Disease Treatment Leqembi
BioArctic's (BIOA-B.ST) partner, Japanese pharmaceutical company Eisai, secured approval in Israel for Leqembi as a treatment for Alzheimer's disease, according to a Friday release.The approval was
List of cloud breakout stocks (Part 1) [Ichimoku Kinko Hyo Cloud Breakout Stock List]
List of high flying stocks in the market: Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Prime <1605> INPEX 2478 2396 2442.5 <1879> Nippon Kenzai 1642 1540.75 1591 <1884> Nichi-doro 1831 1799 1827 <1938>
Biogen, Eisai Say Alzheimer's Drug Leqembi Secures Regulatory Approval in Hong Kong
Biogen (BIIB) and Eisai said Thursday that the Alzheimer's disease drug Leqembi has been approved by Hong Kong's Department of Health.The approval was based on a late-stage trial that met its
The Nikkei Average rose for the third day in a row, with buying of technology stocks and core 30 stocks pushing it to a record high of over 42,000 yen for the first time in history.
On the 10th, the US stock market rose. The Dow Jones Industrial Average closed at 39,721.36, up 429.39 (+1.09%), while the Nasdaq closed at 18,647.45, up 218.16 (+1.18%), and the S&P 500 closed at 5,633.91, up 56.93 (+1.02%). Powell, the chairman of the Federal Reserve Board (FRB), raised expectations of a rate cut in his Senate congressional testimony, causing a rise in the market after the opening. Although the chairman did not clarify the timing in his testimony to the House.
Nikkei Average Contribution Ranking (Before Closing) - Nikkei Average rose for the third consecutive day, with First Retail pushing up about 62 yen with one stock.
As of the close of 11 days ago, the number of rising stocks in the Nikkei average constituent stocks was 178, the number of falling stocks was 45, and the number of unchanged stocks was 2. The Nikkei average has risen for three consecutive days. It closed the morning session at 42,179.84 yen (+0.83%), up 347.85 yen from the previous day (with an estimated trading volume of 910 million shares). The US stock market rose on the 10th. The Dow Jones Industrial Average rose 429.39 points (+1.09%) to 39,721.36, and the Nasdaq rose 218.16 points (+1.18%) to 18,647.
No Data